Opko Health reported $-101650000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2018M 429M
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
ALKERMES ALKS:US $ -30.14M 5.77M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Amarin AMRN:US $ -69.96M 38.39M
Ardelyx ARDX:US $ -26.94M 1.13M
Arrowhead Research ARWR:US $ -72046000 116.41M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Bristol Myers Squibb BMY:US $ 1421M 143M
Emergent Biosolutions EBS:US $ -56.4M 52.7M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Exact Sciences EXAS:US $ -166.06M 14.87M
Exelixis EXEL:US $ 70.67M 2.1M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
Insmed INSM:US $ -95645000 1.02M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Ironwood Pharmaceuticals IRWD:US $ 37.08M 1.72M
Laboratory Of America LH:US $ 358.6M 133M
Lexicon Pharmaceuticals LXRX:US $ -24.59M 1.11M
Moderna Inc MRNA:US 2.2B 1.46B
Myriad Genetics MYGN:US $ -14.1M 6.4M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Opko Health OPK:US $ -101.65M 46.22M
Ptc Therapeutics PTCT:US $ -152.09M 25.36M
Puma Biotechnology PBYI:US $ 9.37M 12.77M
Quest Diagnostics DGX:US $ 234M 121M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Seattle Genetics SGEN:US $ -134.83M 1.67M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
United Therapeutics UTHR:US $ 116M 123.9M